Fri, July 28, 2023
Thu, July 27, 2023
Wed, July 26, 2023

Vamil Divan Maintained (ANIP) at Strong Buy with Increased Target to $62 on, Jul 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-62-on-jul-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vamil Divan of Guggenheim, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $59 to $62 on, Jul 27th, 2023.

Vamil has made no other calls on ANIP in the last 4 months.



There are 3 other peers that have a rating on ANIP. Out of the 3 peers that are also analyzing ANIP, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Vamil


  • Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $60 on, Friday, July 21st, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $60 on, Tuesday, May 9th, 2023
  • Elliot Wilbur of "Raymond James" Maintained at Buy with Increased Target to $49 on, Tuesday, May 9th, 2023

Publication Contributing Sources